|
1
|
Pennica D, Swanson TA, Welsh JW, et al:
WISP genes are members of the connective tissue growth
factor family that are up-regulated in wnt-1-transformed cells and
aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA.
95:14717–14722. 1998. View Article : Google Scholar
|
|
2
|
Zhong N, Gersch RP and Hadjiargyrou M: Wnt
signalling activation during bone regeneration and the role of
Dishevelled in chondrocyte proliferation and differentiation. Bone.
39:5–16. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bork P: The modular architecture of a new
family of growth regulators related to connective tissue growth
factor. FEBS Lett. 327:125–130. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brigstock DR: The CCN family: a new
stimulus package. J Endocrinol. 178:169–175. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang R, Averboukh L, Zhu W, et al:
Identification of rCop-1, a new member of the CCN protein family,
as a negative regulator for cell transformation. Mol Cell Biol.
18:6131–6141. 1998.PubMed/NCBI
|
|
6
|
Kumar S, Hand AT, Connor JR, et al:
Identification and cloning of a connective tissue growth
factor-like cDNA from human osteoblasts encoding a novel regulator
of osteoblast functions. J Biol Chem. 274:17123–17131. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Joliot V, Martinerie C, Dambrine G, et al:
Proviral rearrangements and overexpression of a new cellular gene
(nov) in myeloblastosis-associated virus type 1-induced
nephroblastomas. Mol Cell Biol. 12:10–21. 1992.PubMed/NCBI
|
|
8
|
Mancuso DJ, Tuley EA, Westfield LA, et al:
Structure of the gene for human von Willebrand factor. J Biol Chem.
264:19514–19527. 1989.PubMed/NCBI
|
|
9
|
Hashimoto G, Inoki I, Fujii Y, Aoki T,
Ikeda E and Okada Y: Matrix metalloproteinases cleave connective
tissue growth factor and reactivate angiogenic activity of vascular
endothelial growth factor 165. J Biol Chem. 277:36288–36295. 2002.
View Article : Google Scholar
|
|
10
|
de Winter P, Leoni P and Abraham D:
Connective tissue growth factor: structure-function relationships
of a mosaic, multifunctional protein. Growth Factors. 26:80–91.
2008.PubMed/NCBI
|
|
11
|
Holt GD, Pangburn MK and Ginsburg V:
Properdin binds to sulfatide [Gal(3-SO4)beta 1-1 Cer]
and has a sequence homology with other proteins that bind sulfated
glycoconjugates. J Biol Chem. 265:2852–2855. 1990.
|
|
12
|
Karagiannis ED and Popel AS: Peptides
derived from type I thrombospondin repeat-containing proteins of
the CCN family inhibit proliferation and migration of endothelial
cells. Int J Biochem Cell Biol. 39:2314–2323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Voorberg J, Fontijn R, Calafat J, Janssen
H, van Mourik JA and Pannekoek H: Assembly and routing of von
Willebrand factor variants: the requirements for disulfide-linked
dimerization reside within the carboxy-terminal 151 amino acids. J
Cell Biol. 113:195–205. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brigstock DR, Steffen CL, Kim GY, Vegunta
RK, Diehl JR and Harding PA: Purification and characterization of
novel heparin-binding growth factors in uterine secretory fluids.
Identification as heparin-regulated Mr 10,000 forms of connective
tissue growth factor. J Biol Chem. 272:20275–20282. 1997.
View Article : Google Scholar
|
|
15
|
Holbourn KP, Perbal B and Ravi Acharya K:
Proteins on the catwalk: modelling the structural domains of the
CCN family of proteins. J Cell Commun Signal. 3:25–41. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kubota S and Takigawa M: CCN family
proteins and angiogenesis: from embryo to adulthood. Angiogenesis.
10:1–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Banerjee S, Sengupta K, Saxena NK, Dhar K
and Banerjee SK: Epidermal growth factor induces WISP-2/CCN5
expression in estrogen receptor-α-positive breast tumor cells
through multiple molecular cross-talks. Mol Cancer Res. 3:151–162.
2005.
|
|
18
|
Dhar K, Banerjee S, Dhar G, Sengupta K and
Banerjee SK: Insulin-like growth factor-1 (IGF-1) induces
WISP-2/CCN5 via multiple molecular cross-talks and is essential for
mitogenic switch by IGF-1 axis in estrogen receptor-positive breast
tumor cells. Cancer Res. 67:1520–1526. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sengupta K, Banerjee S, Dhar K, et al:
WISP-2/CCN5 is involved as a novel signalling intermediate in
phorbol ester-protein kinase Cα-mediated breast tumor cell
proliferation. Biochemistry. 45:10698–10709. 2006.PubMed/NCBI
|
|
20
|
Lake AC, Bialik A, Walsh K and Castellot
JJ Jr: CCN5 is a growth arrest-specific gene that regulates smooth
muscle cell proliferation and motility. Am J Pathol. 162:219–231.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dhar G, Mehta S, Banerjee S, et al: Loss
of WISP-2/CCN5 signalling in human pancreatic cancer: a potential
mechanism for epithelial-mesenchymal-transition. Cancer Lett.
254:63–70. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Banerjee S, Dhar G, Haque I, et al:
CCN5/WISP-2 expression in breast adenocarcinoma is associated with
less frequent progression of the disease and suppresses the
invasive phenotypes of tumor cells. Cancer Res. 68:7606–7612. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Inadera H, Hashimoto S, Dong HY, et al:
WISP-2 as a novel estrogen-responsive gene in human breast cancer
cells. Biochem Biophys Res Commun. 275:108–114. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Inadera H, Dong HY and Matsushima K:
WISP-2 is a secreted protein and can be a marker of estrogen
exposure in MCF-7 cells. Biochem Biophys Res Commun. 294:602–608.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Banerjee S, Saxena N, Sengupta K, Tawfik
O, Mayo MS and Banerjee SK: WISP-2 gene in human breast cancer:
estrogen and progesterone inducible expression and regulation of
tumor cell proliferation. Neoplasia. 5:63–73. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zoubine MN, Banerjee S, Saxena NK,
Campbell DR and Banerjee SK: WISP-2: a serum-inducible gene
differentially expressed in human normal breast epithelial cells
and in MCF-7 breast tumor cells. Biochem Biophys Res Commun.
282:421–425. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ray G, Banerjee S, Saxena NK, Campbell DR,
Van Veldhuizen P and Banerjee SK: Stimulation of MCF-7 tumor
progression in athymic nude mice by 17β-estradiol induces
WISP-2/CCN5 expression in xenografts: A novel signalling molecule
in hormonal carcinogenesis. Oncol Rep. 13:445–448. 2005.PubMed/NCBI
|
|
28
|
Davies SR, Watkins G, Mansel RE and Jiang
WG: Differential expression and prognostic implications of the CCN
family members WISP-1, WISP-2, and WISP-3 in human breast cancer.
Ann Surg Oncol. 14:1909–1918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Banerjee SK and Banerjee S: CCN5/WISP-2: a
micromanager of breast cancer progression. J Cell Commun Signal.
6:63–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saxena N, Banerjee S, Sengupta K, Zoubine
MN and Banerjee SK: Differential expression of WISP-1 and WISP-2
genes in normal and transformed human breast cell lines. Mol Cell
Biochem. 228:99–104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tanner MM, Tirkkonen M, Kallioniemi A, et
al: Increased copy number at 20q13 in breast cancer: defining the
critical region and exclusion of candidate genes. Cancer Res.
54:4257–4260. 1994.PubMed/NCBI
|
|
32
|
Bischoff JR, Anderson L, Zhu Y, et al: A
homologue of Drosophila aurora kinase is oncogenic and
amplified in human colorectal cancers. EMBO J. 17:3052–3065.
1998.PubMed/NCBI
|
|
33
|
Davies SR, Davies ML, Sanders A, Parr C,
Torkington J and Jiang WG: Differential expression of the CCN
family members WISP-1, WISP-2 and WISP-3 in human colorectal cancer
and the prognostic implications. Int J Oncol. 36:1129–1136.
2010.PubMed/NCBI
|
|
34
|
Cervello M, Giannitrapani L, Labbozzetta
M, et al: Expression of WISPs and of their novel alternative
variants in human hepatocellular carcinoma cells. Ann NY Acad Sci.
1028:432–439. 2004. View Article : Google Scholar
|
|
35
|
Fukutomi T, Zhou Y, Kawai S, Eguchi H,
Wands JR and Li J: Hepatitis C virus core protein stimulates
hepatocyte growth: correlation with upregulation of wnt-1
expression. Hepatology. 41:1096–1105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tomimaru Y, Koga H, Yano H, de la Monte S,
Wands JR and Kim M: Upregulation of T-cell factor-4
isoform-responsive target genes in hepatocellular carcinoma. Liver
Int. 33:1100–1112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Quan T, Shin S, Qin Z and Fisher GJ:
Expression of CCN family of genes in human skin in vivo and
alterations by solar-simulated ultraviolet irradiation. J Cell
Commun Signal. 3:19–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Colli LM, Saggioro F, Serafini LN, et al:
Components of the canonical and non-canonical Wnt pathways are not
mis-expressed in pituitary tumors. PLoS One. 8:e624242013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ji J, Jia S and Jiang WG: WISP2 is an
independent prognosis indicator of gastric cancer patients and
regulates the biological function of gastric cancer cells via the
JNK pathway. Eur J Cancer. 49:S5722013.
|
|
40
|
Tanaka I, Morikawa M, Okuse T, Shirakawa M
and Imai K: Expression and regulation of WISP2 in rheumatoid
arthritic synovium. Biochem Biophys Res Commun. 334:973–978. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Russo JW and Castellot JJ: CCN5: biology
and pathophysiology. J Cell Commun Signal. 4:119–130. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bejsovec A: Wnt pathway activation: new
relations and locations. Cell. 120:11–14. 2005.PubMed/NCBI
|
|
43
|
De A: Wnt/Ca2+ signalling
pathway: a brief overview. Acta Biochim Biophys Sin. 43:745–756.
2011.
|
|
44
|
Inadera H: Estrogen-induced genes, WISP-2
and pS2, respond divergently to protein kinase pathway. Biochem
Biophys Res Commun. 309:272–278. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wierer M, Verde G, Pisano P, et al: PLK1
signalling in breast cancer cells cooperates with estrogen
receptor-dependent gene transcription. Cell Rep. 3:2021–2032. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ferrand N, Stragier E, Redeuilh G and
Sabbah M: Glucocorticoids induce CCN5/WISP-2 expression and
attenuate invasion in oestrogen receptor-negative human breast
cancer cells. Biochem J. 447:71–79. 2012. View Article : Google Scholar
|
|
47
|
Stiehl DP, Bordoli MR, Abreu-Rodriguez I,
et al: Non-canonical HIF-2α function drives autonomous breast
cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Oncogene.
31:2283–2297. 2012.PubMed/NCBI
|
|
48
|
Delmolino LM, Stearns NA and Castellot JJ
Jr: COP-1, a member of the CCN family, is a heparin-induced growth
arrest specific gene in vascular smooth muscle cells. J Cell
Physiol. 188:45–55. 2001. View Article : Google Scholar
|
|
49
|
Ulrich C, Rolauffs B, Abele H, et al: Low
osteogenic differentiation potential of placenta-derived
mesenchymal stromal cells correlates with low expression of the
transcription factors Runx2 and Twist2. Stem Cells Dev. Jul
20–2013.(Epub ahead of print).
|
|
50
|
Bourdeau I, Antonini SR, Lacroix A, et al:
Gene array analysis of macronodular adrenal hyperplasia confirms
clinical heterogeneity and identifies several candidate genes as
molecular mediators. Oncogene. 23:1575–1585. 2004. View Article : Google Scholar
|
|
51
|
Fritah A, Saucier C, De Wever O, et al:
Role of WISP-2/CCN5 in the maintenance of a differentiated and
noninvasive phenotype in human breast cancer cells. Mol Cell Biol.
28:1114–1123. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dhar G, Banerjee S, Dhar K, et al: Gain of
oncogenic function of p53 mutants induces invasive phenotypes in
human breast cancer cells by silencing CCN5/WISP-2. Cancer Res.
68:4580–4587. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hugo H, Ackland ML, Blick T, et al:
Epithelial-mesenchymal and mesenchymal-epithelial transitions in
carcinoma progression. J Cell Physiol. 213:374–383. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ouelaa-Benslama R, De Wever O, Hendrix A,
et al: Identification of a GαGβγ, AKT and PKCα signalome associated
with invasive growth in two genetic models of human breast cancer
cell epithelial-to-mesenchymal transition. Int J Oncol. 41:189–200.
2012.
|
|
56
|
Sabbah M, Prunier C, Ferrand N, et al:
CCN5, a novel transcriptional repressor of the transforming growth
factor β signalling pathway. Mol Cell Biol. 31:1459–1469.
2011.PubMed/NCBI
|
